Network Pharmacology Analysis of the Targets and Mechanisms of Sang Ju Yin for COVID-19 Treatment
DOI:
https://doi.org/10.47611/jsrhs.v11i4.3729Keywords:
Sang Ju Yin, COVID-19, Network pharmacologyAbstract
As the 2019 coronavirus disease (COVID-19) establishes its prevalence as a global health emergency, novel drugs and medications have become increasingly necessary for prevention and treatment. Traditional Chinese medicine (TCM) has played a pivotal role in containing the virus, and herbal formulas such as Sang Ju Yin have held substantial promise in reducing mortality rates and promoting recovery. However, the exact targets and mechanisms of Sang Ju Yin in COVID-19 treatment have not been extensively explored. Therefore, the objective of this study was to use network pharmacology to identify the interactions between Sang Ju Yin and COVID-19. A total of 170 active ingredients and 1476 targets of Sang Ju Yin were retrieved from multiple databases and combined with 1313 COVID-19 targets to obtain 233 common targets. These core targets were integrated into a protein-protein interaction (PPI) network and active-ingredient-disease-target network using STRING and Cytoscape 3.9.1 software. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed using DAVID and Metascape to determine related biological processes and signaling pathways. The results indicate that Sang Ju Yin likely regulates inflammatory and immune responses in COVID-19 by targeting AKT1, IL-6, and MAPK3. The active ingredients luteolin, kaempferol, and quercetin physically bind to and inhibit the angiotensin converting enzyme 2 (ACE2) and 3-chymotrypsin-like protease (3CLpro) required for viral invasion and replication. The results of this study provide evidence for the therapeutic effects of Sang Ju Yin on COVID-19 and support the application of TCM for treatment worldwide.
Downloads
References or Bibliography
Arghal A., Hafsa S. (2020). A Concise Review of the Popularised Drugs Used For The
Management of COVID-19 (SARS-CoV-2). Archives of Clinical and Biomedical Research 4: 421-425. Retrieved from https://www.fortuneonline.org/articles/a-concise-review-of-the-popularised-drugs-used-for-the-management-of-covid19-sarscov2.html
Bio Essence Health Science. Sang Ju yin- 桑菊飲- Mulberry Leaf & Chrysanthemum decoction. Bio Essence Health Science. (2022). Retrieved August 31, 2022, from https://www.bioessence.com/home/productdetail/100155
Bock K. W. (2020). Aryl hydrocarbon receptor (AHR)-mediated inflammation and
resolution: Non-genomic and genomic signaling. Biochemical pharmacology, 182, 114220. https://doi.org/10.1016/j.bcp.2020.114220
Capodice, J.L., Chubak, B.M. (2021). Traditional Chinese herbal medicine-potential
therapeutic application for the treatment of COVID-19. Chin Med 16, 24. https://doi.org/10.1186/s13020-020-00419-6
Deng Y., Liu B., He Z., Liu T., Zheng R., Yang A. & Xu Y. (2020) Based on network pharmacology and molecular docking method to explore the active compounds of Huoxiangzhengqi oral liquid in the prevention of new coronavirus pneumonia (COVID-19). Chinese Herbal Medicine. Retrieved from https://kns.cnki.net/kcms/detail/12.1108.R.20200224.2202.002.html
Hernández C.C., Payrol J.A., Laime S.G., García A.M., Miche L., et al. (2021) Diabetes COVID-19, potentialities of Morus alba L. (mulberry) and Stevia rebaudiana Bertoni (stevia). Mini-review. Glob J Rare Dis 6(1): 006-009. DOI: 10.17352/2640-7876.000031
Huang, K., Zhang, P., Zhang, Z., Youn, J. Y., Wang, C., Zhang, H., & Cai, H. (2021). Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms. Pharmacology & therapeutics, 225, 107843. https://doi.org/10.1016/j.pharmthera.2021.107843
Jo, S., Kim, S., Shin, D. H., & Kim, M. S. (2020). Inhibition of SARS-CoV 3CL protease by flavonoids. Journal of enzyme inhibition and medicinal chemistry, 35(1), 145–151. https://doi.org/10.1080/14756366.2019.1690480
Kumar, G., Afaq, U., Pathak, B.C., Gupta, B.K. (2020). Complementary Herbal Remedies Currently Used Against COVID-19. National Webinar on Impact of COVID-19 Pandemic and Future Prospects. Retrieved from https://www.researchgate.net/profile/Gyanendra-Kumar-14/publication/350579953_COMPLEMENTARY_HERBAL_REMEDIES_CURRENTLY_USED_AGAINST_COVID-19/links/6066c0cd92851c91b1988b46/COMPLEMENTARY-HERBAL-REMEDIES-CURRENTLY-USED-AGAINST-COVID-19.pdf
Kumari, R., Kumar, S. (2020). Pharmacological Approaches to Investigate the Potential Herbal Medicine (Decoction) in Treating COVID-19. ACTA Scientific Agriculture 4, 7. Retrieved from https://www.researchgate.net/profile/Sanjay-Kumar-97/publication/348182128_Pharmacological_Approaches_to_Investigate_the_Potential_Herbal_Medicine_Decoction_in_Treating_COVID-19/links/5ff2bab5299bf140886c6d10/Pharmacological-Approaches-to-Investigate-the-Potential-Herbal-Medicine-Decoction-in-Treating-COVID-19.pdf
Li, P., Hu, S., Qian, C., Yao, Y., Li, L. Y., Yang, J. F., Yang, L., Yang, C. C., Zhou, H., Wang, S. X., Hu, Y., Zhu, X. Y., Zhou, J., Pan, L. X., Shen, C. P., & Zhou, H. (2021). The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19. Frontiers in pharmacology, 12, 650425. https://doi.org/10.3389/fphar.2021.650425
Liu, J., Yuan, S., Yao, Y., Wang, J., Scalabrino, G., Jiang, S., & Sheridan, H. (2022). Network Pharmacology and Molecular Docking Elucidate the Underlying Pharmacological Mechanisms of the Herb Houttuynia cordata in Treating Pneumonia Caused by SARS-CoV-2. Viruses, 14(7), 1588. https://doi.org/10.3390/v14071588
Luo, H., Gao, Y., Zou, J. et al. (2020) Reflections on treatment of COVID-19 with traditional Chinese medicine. Chin Med 15, 94. https://doi.org/10.1186/s13020-020-00375-1
Mirzaie, A., Halaji, M., Dehkordi, F. S., Ranjbar, R., & Noorbazargan, H. (2020). A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complementary therapies in clinical practice, 40, 101214. https://doi.org/10.1016/j.ctcp.2020.101214
Nguyen, T.T.H., Woo, HJ., Kang, HK. et al. (2012)Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris . Biotechnol Lett 34, 831–838. https://doi.org/10.1007/s10529-011-0845-8
Niu, W. H., Wu, F., Cao, W. Y., Wu, Z. G., Chao, Y. C., & Liang, C. (2021). Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6. Bioscience reports, 41(1), BSR20202583. https://doi.org/10.1042/BSR20202583
Poon, P. M., Wong, C. K., Fung, K. P., Fong, C. Y., Wong, E. L., Lau, J. T., Leung, P. C., Tsui, S. K., Wan, D. C., Waye, M. M., Au, S. W., Lau, C. B., & Lam, C. W. (2006) Immunomodulatory effects of a traditional Chinese medicine with potential antiviral activity: a self-control study. The American journal of Chinese medicine, 34(1), 13–21. https://doi.org/10.1142/S0192415X0600359X
Qiao, L., Huang, W., Zhang, X. et al. (2021). Evaluation of the immunomodulatory effects of anti-COVID-19 TCM formulae by multiple virus-related pathways. Sig Transduct Target Ther 6, 50. https://doi.org/10.1038/s41392-021-00475-w
Tao, Q., Du, J., Li, X., Zeng, J., Tan, B., Xu, J., Lin, W., & Chen, X. L. (2020). Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19. Drug development and industrial pharmacy, 46(8), 1345–1353. https://doi.org/10.1080/03639045.2020.1788070
Tong, T., Wu, YQ., Ni, WJ. et al. (2020). The potential insights of Traditional Chinese Medicine on treatment of COVID-19. Chin Med 15, 51. https://doi.org/10.1186/s13020-020-00326-w
U.S. Food and Drug Administration. (2022, May). FDA has approved two drugs and authorized others for emergency use. U.S. Food and Drug Administration. Retrieved August 31, 2022, from https://www.fda.gov/consumers/consumer-updates/know-your-treatment-options-covid-19#:~:text=What%20treatments%20are%20available%20for,hospitalized%20adults%20with%20COVID%2D19
Ullah, A., Munir, S., Badshah, S. L., Khan, N., Ghani, L., Poulson, B. G., Emwas, A. H., & Jaremko, M. (2020). Important Flavonoids and Their Role as a Therapeutic Agent. Molecules (Basel, Switzerland), 25(22), 5243. https://doi.org/10.3390/molecules25225243
Wang, J., Qi, F. (2020). Traditional Chinese medicine to treat COVID-19: the importance of evidence-based research. Drug Discoveries & Therapeutics. 2020; 14(3):149-150. https://doi.org/10.5582/ddt.2020.03054
Wang, M. Y., Zhao, R., Gao, L. J., Gao, X. F., Wang, D. P., & Cao, J. M. (2020). SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development. Frontiers in cellular and infection microbiology, 10, 587269. https://doi.org/10.3389/fcimb.2020.587269
World Health Organization. (2022). WHO coronavirus (COVID-19) dashboard. World Health Organization. Retrieved August 31, 2022, from https://covid19.who.int/
Wu, Z., Chen, X., Ni, W., Zhou, D., Chai, S., Ye, W., Zhang, Z., Guo, Y., Ren, L., & Zeng, Y. (2021). The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study. RSC advances, 11(20), 11821–11843. https://doi.org/10.1039/d0ra07035a
Wu H., Wang J., Yang Y., Li T., Cao Y., Qu Y. & Sun Y. (2020). Preliminary exploration of the mechanism of "Qingfei Paidu Decoction" against novel coronavirus pneumonia based on network pharmacology and molecular docking technology. Chinese Journal of Pharmacy (03), 374-383. https://doi.org/10.16438/j.0513-4870.2020-0136
Xia, Q. D., Xun, Y., Lu, J. L., Lu, Y. C., Yang, Y. Y., Zhou, P., Hu, J., Li, C., & Wang, S. G. (2020). Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19. Cell proliferation, 53(12), e12949. https://doi.org/10.1111/cpr.12949
Xing, Y., Hua, Y. R., Shang, J., Ge, W. H., & Liao, J. (2020). Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019. Chinese journal of natural medicines, 18(12), 941–951. https://doi.org/10.1016/S1875-5364(20)60038-3
Xu, J., Zhang, Y. (2020). Traditional Chinese Medicine Treatment of COVID-19. ScienceDirect, 39, 101165. https://doi.org/10.1016/j.ctcp.2020.101165
Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2020). Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. International journal of biological sciences, 16(10), 1708–1717. https://doi.org/10.7150/ijbs.45538
Yu, B., Lin, F., Ning, H., & Ling, B. (2021). Network pharmacology study on the mechanism of the Chinese medicine Radix Isatidis (Banlangen) for COVID-19. Medicine, 100(32), e26881. https://doi.org/10.1097/MD.0000000000026881
Yu, J. W., Wang, L., & Bao, L. D. (2020). Exploring the active compounds of traditional Mongolian medicine in intervention of novel coronavirus (COVID-19) based on molecular docking method. Journal of functional foods, 71, 104016. https://doi.org/10.1016/j.jff.2020.104016
Zhang, Z. Diagnosis and treatment protocol for COVID-19 patients (Trial Version 9). Health Care Sci. 2022; 1: 14– 28. https://doi.org/10.1002/hcs2.1
Zhang, Z. J., Wu, W. Y., Hou, J. J., Zhang, L. L., Li, F. F., Gao, L., Wu, X. D., Shi, J. Y., Zhang, R., Long, H. L., Lei, M., Wu, W. Y., Guo, D. A., Chen, K. X., Hofmann, L. A., & Ci, Z. H. (2020). Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MSE analysis. Journal of integrative medicine, 18(3), 229–241. https://doi.org/10.1016/j.joim.2020.03.004
Zhao, Z., Li, Y., Zhou, L., Zhou, X., Xie, B., Zhang, W., & Sun, J. (2021). Prevention and treatment of COVID-19 using Traditional Chinese Medicine: A review. Phytomedicine : international journal of phytotherapy and phytopharmacology, 85, 153308. https://doi.org/10.1016/j.phymed.2020.153308
Zong Y., Ding M., Jia K., Ma S. & Ju W. (2020) Based on network pharmacology and
molecular docking method to explore the active compounds of Dayuan drink in the treatment of new coronavirus (2019-nCoV) pneumonia. Chinese Herbal Medicine. Retrieved from https://kns.cnki.net/kcms/detail/12.1108.r.20200209.1038.002.html
Published
How to Cite
Issue
Section
Copyright (c) 2022 Isabelle Li
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
